the total amount paid out in critical illness claims was £75.19m, with cancer accounting for 74 per cent of claims from women, mainly breast cancer, alongside 51 per cent from men...
.
why novartis� landmark cancer drug approval is great news for bluebird.
three other countries � spain, czech republic, and slovakia � had also been warned by the eu, but devised sufficient air management plans within the requested time frame..